rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and Highly Infectious in Healthy Adult Volunteers
- 1 March 2005
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 191 (5) , 710-718
- https://doi.org/10.1086/427780
Abstract
BackgroundThe live attenuated dengue virus type 4 (DEN-4) vaccine candidate virus rDEN4Δ30 was previously found to be safe and immunogenic at a dose of 105 plaque-forming units (pfu)Keywords
This publication has 0 references indexed in Scilit: